In RD cells, SU14813 had a 50% cytotoxicity concentration (CC50) of 26.35 ± 6.09 μM. In SK‐MEL‐28 cells treated with 10 µM SU14813 for 48 h, CETSA showed that SU14813 binding significantly reduced WDR12 thermal stability, decreasing the Tm from 63.63°C in the control group to 57.38°C in the SU14813‐treated group. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
50% cytotoxicity concentration (CC50) in RD cells
Cell-based study · RD cells [1]
Model: RD cells. Result: 26.35 ± 6.09 μM.
Literature-Reported Treatment Conditions
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle, control.
Methods and source locations
Compound reported in the paper: SU14813
The paper names SU14813 without stating the salt or form; not verified as the maleate form supplied as A11556. No dose conversion or lot validation.
RESULTS > Inhibition of EV-A71 infection in vitro by VEGFR inhibitors (S73); TABLE 1 (T1.h1, T1.r4)
50% cytotoxicity concentration (CC50): 50% cytotoxicity concentration (CC50) — RESULTS > Inhibition of EV-A71 infection in vitro by VEGFR inhibitors (S73); TABLE 1 (T1.h1, T1.r4)
Protein Thermal Stability in Melanoma Cells
Cell-based study · SK‐MEL‐28 cells [2]
SK‐MEL‐28 cells were treated with DMSO or 10 µM SU14813 for 48 h and assessed by CETSA. SU14813 binding significantly reduced WDR12 thermal stability, decreasing the Tm from 63.63°C in the control group to 57.38°C in the SU14813‐treated group.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 µM
- Exposure duration
- for 48 h
- Method
- treated with DMSO or SU14813
- Vehicle
- DMSO
Methods and source locations
Compound reported in the paper: SU14813
The paper names SU14813 without stating the salt or form; not verified as the maleate form supplied as A11556. No dose conversion or lot validation.
Results > The Small‐Molecule Compound SU14813 Targeting WDR12 Downregulates CD276 and Potentiates CD8+ T‐Cell Antitumor Function (S89); FIGURE 5 legend (S278, S279)
CETSA analysis of SU14813 on the thermal stability of target protein WDR12: CETSA analysis of SU14813 on the thermal stability of target protein WDR12; comparator: DMSO — Results > The Small‐Molecule Compound SU14813 Targeting WDR12 Downregulates CD276 and Potentiates CD8+ T‐Cell Antitumor Function (S89); FIGURE 5 legend (S278)